AAM
GH icon

Ardevora Asset Management’s Guardant Health GH Stock Holding History

Ardevora Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-441,220
Closed -$55.2M – 144
2021
Q3 		$55.2M Buy
441,220
+2,800
+0.6% +$333K 0.7% 108
2021
Q2 		$54.4M Buy
438,420
+90,798
+26% +$12.2M 0.69% 111
2021
Q1 		$53.1M Sell
347,622
-122,736
-26% -$18.5M 0.79% 74
2020
Q4 		$60.6M Buy
+470,358
New +$54.1M 0.94% 35

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Ardevora Asset Management's GH Position: Q4 2021 in Review

Ardevora Asset Management sold out of Guardant Health (GH) in Q4 2021, closing a stake of 441,220 shares — an estimated $55.2M sold.

Ardevora Asset Management first reported a position in GH in Q4 2020 and held it in 4 quarters. The position peaked at $60.6M in Q4 2020. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • Ardevora Asset Management reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • Ardevora Asset Management sold 441,220 Guardant Health shares in Q4 2021, an estimated $55.2M.
  • Ardevora Asset Management first reported a position in Guardant Health in Q4 2020 and held it in 4 quarters.
  • Ardevora Asset Management's Guardant Health position peaked at $60.6M in Q4 2020.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Ardevora Asset Management's 13F filing for Q4 2021, filed 31 Jan 2022.